allergic diseases
Conditions
Interventions
None listed
Sponsors
Takigawa Shingo
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Subject Selection Policy Individuals who have not experienced satisfactory results in the treatment of diseases with standard therapy. Individuals who, due to concerns about side effects, do not wish to undergo treatment with drugs commonly used in standard therapy and are deemed suitable for treatment with cultured supernatant by a physician. The following are the selection criteria for patients: Inclusion Criteria: Patients meeting the following criteria will be eligible for the study: Individuals aged 18 years or older. Individuals who possess normal cognitive capacity. Individuals who can provide written informed consent based on a thorough explanation provided by the physician, after receiving a consent form related to this treatment. Individuals for whom the attending physician recognizes the necessity of treatment.
Exclusion criteria
Exclusion criteria: Exclusion Criteria: Individuals who meet any of the following conditions will be excluded: Users of narcotics or stimulants. Individuals deemed unsuitable by the attending physician.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Improvement of subjective symptoms | — |
Contacts
Public ContactIshiwata Yoshikazu
Kawagoe Chuou Cinic
Outcome results
None listed